HS-20094 Injection for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Sep 2025: Trial registered, NCT07156539

The trials

NCT07156539: A Phase 3 Study of HS-20094 in Patients With T2DM

State
Not started
Phase
Phase 3
People
546 planned
Started
30 Sep 2025
Primary completion
30 Mar 2027
Arms
Treatment Group A, Treatment Group B
Results
None posted
  1. 5 Sep 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.